These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 24617534)
1. Acute cellular rejection with isolated v-lesions is not associated with more favorable outcomes than vascular rejection with more tubulointerstitial inflammations. Wu KY; Budde K; Schmidt D; Neumayer HH; Rudolph B Clin Transplant; 2014 Apr; 28(4):410-8. PubMed ID: 24617534 [TBL] [Abstract][Full Text] [Related]
2. The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomes. Wu K; Budde K; Lu H; Schmidt D; Liefeldt L; Glander P; Neumayer HH; Rudolph B Transplantation; 2014 Jun; 97(11):1146-54. PubMed ID: 24892962 [TBL] [Abstract][Full Text] [Related]
3. The Relationship of the Severity and Category of Acute Rejection With Intimal Arteritis Defined in Banff Classification to Clinical Outcomes. Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B Transplantation; 2015 Aug; 99(8):e105-14. PubMed ID: 25719260 [TBL] [Abstract][Full Text] [Related]
4. Designation of T-cell-mediated rejection type Ib and IIa reflects the type of rejection rather than the severity in the Banff classification. Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B Exp Clin Transplant; 2014 Oct; 12(5):415-23. PubMed ID: 25299369 [TBL] [Abstract][Full Text] [Related]
6. Pathologic characteristics of early or late acute cellular rejection and outcome after kidney transplant. Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B Exp Clin Transplant; 2014 Aug; 12(4):314-22. PubMed ID: 25095709 [TBL] [Abstract][Full Text] [Related]
7. Isolated v-lesion represents a benign phenotype of vascular rejection of the kidney allograft - a retrospective study. Novotny M; Hruba P; Vichova P; Maluskova J; Honsova E; Viklicky O; Wohlfahrtova M Transpl Int; 2018 Oct; 31(10):1153-1163. PubMed ID: 29855106 [TBL] [Abstract][Full Text] [Related]
8. C4d deposits in acute "cell-mediated" rejection: a marker for renal prognosis? Neves M; Cotovio P; Machado S; Santos L; Macário F; Alves R; Pratas J; Xavier da Cunha M; Mota A; Campos M Transplant Proc; 2012 Oct; 44(8):2360-5. PubMed ID: 23026593 [TBL] [Abstract][Full Text] [Related]
9. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109 [TBL] [Abstract][Full Text] [Related]
18. Clinical and Pathological Analyses of Cases of Acute Vascular Rejection After Kidney Transplantation. Shimizu T; Ishida H; Hayakawa N; Shibahara R; Tanabe K Transplant Proc; 2017 Dec; 49(10):2251-2255. PubMed ID: 29198655 [TBL] [Abstract][Full Text] [Related]
19. Influence of delayed graft function and acute rejection on outcomes after kidney transplantation from donors after cardiac death. Nagaraja P; Roberts GW; Stephens M; Horvath S; Fialova J; Chavez R; Asderakis A; Kaposztas Z Transplantation; 2012 Dec; 94(12):1218-23. PubMed ID: 23154212 [TBL] [Abstract][Full Text] [Related]